⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15827088 | 0.85 | — | — | |
| SCHEMBL22419945 | 0.84 | ALDH1A1 (0.31) | — | |
| SCHEMBL12173948 | 0.84 | — | — | |
| SCHEMBL20121890 | 0.81 | MEN1 (0.37) | — | |
| SCHEMBL17351994 | 0.81 | — | — | |
| SCHEMBL22898891 | 0.80 | — | — | |
| SCHEMBL23995573 | 0.75 | — | — | |
| SCHEMBL24065092 | 0.71 | — | — | |
| SCHEMBL16937570 | 0.71 | — | — | |
| SCHEMBL23586972 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210138020-A1 | WEEKLY DOSING REGIMENS FOR ANTI-CD30 VC-PAB-MMAE ANTIBODY DRUG-CONJUGATES | SEAGEN INC. (US) | 2021-05-13 | — | — | US | disclosed |